Search - tctmd.com

Displaying 281 - 300 of 2624

Sort: Relevancy | Date

Presentation TVT 2016

TAVR in Mitral Valve Bioprothesis (VIV): Anatomical Considerations

Presenter: Danny Dvir

June 16, 2016

Presentation TVT 2016

TVT 1063: What Is the Optimal Treatment for Residual Commissural Jet Following MitraClip? Ventricular Septal Defect Occluder Device vs Gore CARDIOFORM

Presenter: Yoshifumi Nakajima, MD

June 16, 2016

Presentation TVT 2016

The Minimalist TAVR Credo: Keep It Simple! Impact on Clinical Pathway Efficiencies and Outcomes

Presenter: Vasilis Babaliaros

June 16, 2016

Presentation TVT 2016

TVT 1036: Concurrent Transcatheter Double Valve Replacement: First Report of Sapien 3 Implantation in Native Aortic and Mitral Annuli in the Same Setting

Presenter: Vikas Aggarwal, MD

June 16, 2016

Presentation TVT 2016

TVT 1123: TAVR Valve Used to Treat Native Mitral Regurgitation A Hybrid Surgical Transcatheter Approach

Presenter: Creighton W. Don

June 16, 2016

Presentation TVT 2016

TAVR Bioskills

Presenter: Mark Reisman

June 16, 2016

Presentation TVT 2016

Appropriate Use of TAVR Now and in the Future: A Surgeons Perspective

Presenter: Neil E. Moat

June 16, 2016

Presentation TVT 2016

The Relentless Journey of TAVR to Lower-Risk Patients: Are We There Yet?

Presenter: Martin B. Leon

June 16, 2016

News Conference News TVT 2016

Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes

Michael O'Riordan

June 16, 2016

News Daily News

患者在 TAVR 后感染性心内膜炎的死亡率高，应予以更好的预防和治疗

Yael L. Maxwell

June 15, 2016

News Daily News

La Alta Mortalidad que Sobreviene tras una Endocarditis Infecciosa Post-TAVR Justifica Mejores Medidas de Prevención y Tratamiento

Yael L. Maxwell

June 15, 2016

News Daily News

High Mortality Following Infective Endocarditis After TAVR Warrants Better Prevention, Treatment

Yael L. Maxwell

June 15, 2016

News Daily News

MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes

Shelley Wood

June 14, 2016

Presentation

Incidence, Predictors, and Outcome of Patients Developing Infective Endocarditis (IE) Following Transfemoral TAVR

Presenter: Norman Mangner

June 14, 2016

Presentation SOLACI 2016

TAVI - Indicações E Resultados Atuais

Presenter: Luiz Antonio Carvalho

June 10, 2016

Presentation SOLACI 2016

Medtronic Evolut R System

Presenter: Eberhard Grube

June 10, 2016

Presentation SOLACI 2016

Future Directions in TAVR: From Moderate-Low Risk Patients to New Devices

Presenter: Martin B. Leon

June 10, 2016

Presentation SOLACI 2016

Software “syngo Aortic Valve Guidance” para procedimentos de TAVI

Presenter: Ari Mandil

June 09, 2016

Presentation SOLACI 2016

Complex Cases in TAVI: Our Experience With the Last Generation Valves

Presenter: Vin?cius Esteves

June 09, 2016

News Daily News

More Proof of Declining Paravalvular Regurgitation With Newest Balloon-Expandable TAVR Devices

Shelley Wood

June 07, 2016

Advertisement

TAVR in Mitral Valve Bioprothesis (VIV): Anatomical Considerations

TVT 1063: What Is the Optimal Treatment for Residual Commissural Jet Following MitraClip? Ventricular Septal Defect Occluder Device vs Gore CARDIOFORM

The Minimalist TAVR Credo: Keep It Simple! Impact on Clinical Pathway Efficiencies and Outcomes

TVT 1036: Concurrent Transcatheter Double Valve Replacement: First Report of Sapien 3 Implantation in Native Aortic and Mitral Annuli in the Same Setting

TVT 1123: TAVR Valve Used to Treat Native Mitral Regurgitation A Hybrid Surgical Transcatheter Approach

TAVR Bioskills

Appropriate Use of TAVR Now and in the Future: A Surgeons Perspective

The Relentless Journey of TAVR to Lower-Risk Patients: Are We There Yet?

Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes

患者在 TAVR 后感染性心内膜炎的死亡率高，应予以更好的预防和治疗

La Alta Mortalidad que Sobreviene tras una Endocarditis Infecciosa Post-TAVR Justifica Mejores Medidas de Prevención y Tratamiento

High Mortality Following Infective Endocarditis After TAVR Warrants Better Prevention, Treatment

MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes

Incidence, Predictors, and Outcome of Patients Developing Infective Endocarditis (IE) Following Transfemoral TAVR

TAVI - Indicações E Resultados Atuais

Medtronic Evolut R System

Future Directions in TAVR: From Moderate-Low Risk Patients to New Devices

Software “syngo Aortic Valve Guidance” para procedimentos de TAVI

Complex Cases in TAVI: Our Experience With the Last Generation Valves

More Proof of Declining Paravalvular Regurgitation With Newest Balloon-Expandable TAVR Devices

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content